Saint Marys Healthcare Chemical Dependency Outpatient Clinic
-
Services:
- Sliding fee scale (fee is based on income and other factors)
- Payment assistance (check with facility for details)
- Substance use disorder counseling
- Telemedicine/telehealth therapy
- Matrix Model
- Cognitive behavioral therapy
- Anger management
- Relapse prevention
- 12-step facilitation
- Trauma-related counseling
- Motivational interviewing
- Vaping permitted in designated area
- No formal relationship with prescribing entity
- In-network prescribing entity
- Outpatient detoxification
- Regular outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient
- Intensive outpatient treatment
- State Substance use treatment agency
- State department of health
- The Joint Commission
- STD testing
- Drug and alcohol oral fluid testing
- TB screening
- HIV testing
- Breathalyzer or blood alcohol testing
- Testing for Hepatitis C (HCV)
- Drug or alcohol urine screening
- Testing for Hepatitis B (HBV)
- Private health insurance
- State-financed health insurance plan other than Medicaid
- Federal, or any government funding for substance use treatment programs
- Medicare
- Cash or self-payment
- Federal military insurance (e.g., TRICARE)
- Medicaid
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Male
- Female
- Complete medical history/physical exam
- Screening for substance use
- Screening for tobacco use
- Screening for mental disorders
- Comprehensive substance use assessment
- Group counseling
- Family counseling
- Smoking/vaping/tobacco cessation counseling
- Hepatitis education, counseling, or support
- HIV or AIDS education, counseling, or support
- Health education services other than HIV/AIDS or hepatitis
- Substance use disorder education
- Individual counseling
- Discharge Planning
- Naloxone and overdose education
- Aftercare/continuing care
- Sign language services for the deaf and hard of hearing
- Opioids detoxification
- Medication routinely used during detoxification
- Benzodiazepines Detoxification
- Methamphetamines detoxification
- Cocaine Detoxification
- Alcohol Detoxification
- Social skills development
- Suicide prevention services
- Case management service
- Disulfiram
- Acamprosate (CampralĀ®)
- Medication for mental disorders
- Naltrexone (oral)
- Naltrexone (extended-release, injectable)
- Clonidine
- Nicotine replacement
- Buprenorphine with naloxone
- Buprenorphine without naloxone
- Non-nicotine smoking/tobacco cessation
- General Hospital (including VA hospital)
- Adult women
- Adult men
- Clients with co-occurring mental and substance use disorders
- Criminal justice (other than DUI/DWI)/Forensic clients
- Self-help groups
- Mentoring/peer support
- Housing services
- Assistance with obtaining social services
- In-network prescribing entity
- Smoking permitted in designated area
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Accepts clients using MAT but prescribed elsewhere
- Relapse prevention with naltrexone
- Prescribes naltrexone
- Prescribes buprenorphine
- Private non-profit organization
- Children/Adolescents
- Detoxification
- Substance use treatment
Payment Assistance Available
Treatment Approaches
Facility Vaping Policy
External Source of Medications Used for Alcohol Use Disorder Treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
License/Certification/Accreditation
Testing
Payment/Insurance/Funding Accepted
Type of Alcohol Use Disorder Treatment
Gender Accepted
Assessment/Pre-treatment
Education and Counseling Services
Transitional Services
Language Services
Detoxification (medical withdrawal) Services
Ancillary Services
Pharmacotherapies
Hospitals
Special Programs/Groups Offered
Recovery Support Services
External Opioid Medications Source
Facility Smoking Policy
Opioid Medications used in Treatment
Type of Opioid Treatment
Facility Operation (e.g., Private, Public)
Age Groups Accepted
Type of Care